Hexapeptide-2:Acts as a Safe Brightening Peptide for Cosmetic Formulations

Hexapeptide-2 is a high-purity synthetic cosmetic-grade hexapeptide, listed in China’s Catalogue of Used Cosmetic Raw Materials (2021 Edition) with CAS 137665-91-7. As a mild and efficient brightening peptide, it has gained wide recognition globally for its safe mechanism, stable performance and excellent skin compatibility.

Manufactured via advanced solid-phase peptide synthesis, it has a purity ≥98%, appearing as a fine white powder with good water solubility, high stability and broad formulation compatibility. Low‑irritation and non‑sensitizing, it does not damage the skin barrier and is clinically proven safe for long-term daily use.

Its core mechanism is dual-target regulation: competitively binding to α-MSH receptors to block melanin synthesis signals, and inhibiting melanosome transfer to keratinocytes. It reduces pigment deposition, brightens dull skin and prevents new spots without irritating melanocytes.

Skin Benefits & Mechanism of Action

Hexapeptide-2 delivers multi-dimensional brightening, anti-pigmentation and conditioning effects, focusing on melanin control, dullness correction and barrier care, suitable for all skin types including sensitive skin.

It inhibits melanin synthesis and transfer, fading dark spots. By down-regulating tyrosinase activity and interrupting melanosome transport, it reduces sun spots, acne marks and superficial pigmentation. 28-day continuous use visibly evens skin tone, dullness reduced by up to 58%, delaying UV-induced darkening.

It brightens complexion and refines skin texture. Accelerates epidermal metabolism, removes dull keratin, improves rough and matte skin. Enhances translucency and radiance, relieves sallowness, smooths fine lines and improves elasticity, ideal for dull, uneven and photoaged skin.

Mild and skin-friendly for sensitive skin. Comedogenic rating 0/5, non-comedogenic and low-irritation. Rarely causes allergy; mild redness resolves naturally. Supports barrier stability, reduces dryness and sensitivity, maintaining long-term skin health.

Synergistic with other actives. Highly compatible with vitamin C derivatives, niacinamide, tranexamic acid and arbutin to amplify brightening. Works with hyaluronic acid for hydration, and centella extract for soothing, achieving brightening, moisturizing and calming together.

Application Challenges & Practical Solutions

As a core brightening raw material, Hexapeptide-2 faces typical formulation and production challenges, summarized in Q&A format:

Q: What stability issues may occur in formulations?

A: Generally stable, but high concentration of strong acids/alkalis, high temperature or incompatible ingredients may reduce activity or cause flocculation/discoloration. Recommended pH 5.0–7.0 and low‑temperature processing.

Q: How to improve transdermal absorption?

A: Molecular weight ~850 Da limits penetration. Liposome encapsulation, nano-carriers or particle size <20 nm can boost transdermal efficiency by up to 280%.

Q: Any compatibility conflicts?

A: Broadly compatible, but high-dose alcohol or strong preservatives may reduce activity; heavy oils may cause turbidity. Adjust pH and add stabilizers to resolve.

Q: Storage and shelf life requirements?

A: Store freeze-dried powder in cool, dry, dark place. Reconstituted solution: 48 h RT, 7 days refrigerated.

Q: Does it cause redness or stinging?

A: No. Low-sensitization (0/5). Irritation usually comes from other ingredients in the formula.

Terminal Applications & Market Prospects

Driven by demand for mild, safe brightening, Hexapeptide-2 market grows steadily. 2024 global market ~USD 48 million, projected >USD 100 million by 2033, CAGR 7.5% (2026-2033). China market CAGR >18% in next five years.

Main terminal applications include brightening and spot-correcting serums with typical addition levels of 0.5%-5.0%, whitening and rejuvenation creams and lotions, soothing brightening masks and ampoules, eye creams targeting dullness and dark circles, body brightening lotions and sun care products, as well as post-procedure repair formulations to reduce post-inflammatory hyperpigmentation (PIH).

Technological progress enables ≥99% purity mass production, lowering cost and accelerating import substitution. Innovation focuses on transdermal enhancement and formulation stability. Stricter regulations drive standardization and competition.

Hexapeptide-2 perfectly matches consumers’pursuit of gentle, safe and effective brightening, with strong growth potential and broad prospects in global cosmetics.

Name: Chloe Liang

Email: sales10@aogubio.com

Whatsapp: +86-18161805635

Website: www.aogubio.com